That is the quick version
By copying the components of a hormone called glucagon-like peptide-1 (GLP-1), Zepbound can help to reduce hunger and increase feelings of being full, which ends up in weight loss
Its weight-management evidence comes largely from the STEP program published in The New England Journal of Medicine in 2021
Nausea is by far the most commonly reported symptom and tends to appear early, especially during dose increases. Vomiting, diarrhea, and constipation can also occur, though their frequency depends on the specific medication and dose
Abstract Objective To evaluate the association between pretreatment with the glucagon-like peptide-1 receptor agonist semaglutide and reproductive outcomes in women with overweight and obesity with infertility
For instance, in one 1960s study of intravenous NAD+ for addiction, patients who received a fast IV drip experienced immediate headache and shortness of breath, whereas those given the same dose at a slower drip rate (under approximately 35 drops/min) had no distress